Results 121 to 130 of about 372,210 (165)

Factors Affecting Continued Use of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC): A Secondary Analysis of a 1-Year Randomized Trial in Malawi. [PDF]

Glob Health Sci Pract, 2019
Burke HM, Chen M, Buluzi M, Fuchs R, Wevill S, Venkatasubramanian L, Santo LD, Ngwira B.   +7 more
europepmc   +1 more source

PENGARUH FREKUENSI KONTRASEPSI SUNTIK DMPA TERHADAP KENAIKAN BERAT BADAN PADA AKSEPTOR KONTRASEPSI SUNTIK DMPA

Family Planning in one of the based and prominent healthy preventive service for women. Mostly Injection contraception device is used by mothers. Beside has benefits contraception device also has many side effects especially for DMPA injection Family ...
Aris Santjaka, SUMARNI, Dewi Dwi Haryani
core  

Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries. [PDF]

Glob Health Sci Pract, 2018
Stout A, Wood S, Barigye G, Kaboré A, Siddo D, Ndione I.   +5 more
europepmc   +1 more source

Setbacks in continuing self-injection of DMPA-SC: a descriptive study of provider and mystery client reports on the DMPA-SC care-seeking experience in Nigeria

Madeline Griffith, Sneha Challa, Ayobambo Jegede, Ivan Idiodi, Chioma Okoli, Aminat Tijani, Shakede Dimowo, Awawu Grace Nmadu, Elizabeth Omoluabi, Jenny Liu   +9 more
openaire   +1 more source

Consistency of on-the-job training implementation for subcutaneous depot medroxyprogesterone acetate in Ghana and associated healthcare worker knowledge transfer: A cross-sectional mixed-methods study. [PDF]

PLOS Glob Public Health
Porter Erlank C, Bentsi-Enchill M, Tagoe S, Amedoe JA, Stanley M, Diogo CA, Issah K.   +6 more
europepmc   +1 more source

Alleviating price and information barriers to long-acting contraception uptake in Kenyan pharmacies using patient and provider incentives: a cluster randomized control trial. [PDF]

EClinicalMedicine
Dieci M, Paramo C, Gertler PJ.
europepmc   +1 more source

Barriers and Facilitators to Expanding User-Administered Injectable Contraceptives in the United States. [PDF]

O G Open
Clark C, Cheng AL, Creason L, Karlin J.
europepmc   +1 more source

Erratum for: Odwe et al., Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Injectable Contraception at Facility and Community Levels: Pilot Results From 4 Districts of Uganda. [PDF]

Glob Health Sci Pract, 2019
europepmc   +1 more source

Return to fertility after subcutaneous depot medroxyprogesterone acetate: a narrative review. [PDF]

BMJ Sex Reprod Health
Osoti A, Kidula N, Mengesa LB, Kiarie JN.   +3 more
europepmc   +1 more source

Understanding Clients’ and Providers’ Perspectives on the Implementation of DMPA-SC for Self-injection Programming in Nigeria

Sneha Challa, Madeline Griffith, Ayobambo Jegede, Aminat Tijani, Emily Himes, Ivan Idiodi, Chioma Okoli, Shakede Dimowo, Elizabeth Omoluabi, Jenny Liu   +9 more
openaire   +1 more source